SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-004708
Filing Date
2022-02-11
Accepted
2022-02-11 09:48:06
Documents
13
Period of Report
2022-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtcr-8k_20220210.htm   iXBRL 8-K 54225
2 EX-99.1 mtcr-ex991_29.htm EX-99.1 10508
  Complete submission text file 0001564590-22-004708.txt   205778

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220210.xsd EX-101.SCH 5697
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220210_lab.xml EX-101.LAB 20169
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220210_pre.xml EX-101.PRE 12037
7 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-8k_20220210_htm.xml XML 3678
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 22617221
SIC: 2834 Pharmaceutical Preparations